IRVINE, Calif., Oct. 10, 2005 (PRIMEZONE) -- "The message is clear, the baby boomers are getting older and healthcare had better be ready," stated SmallCap Sentinel analyst D.R. Clark. "Savvy public companies will be waiting to meet them with innovation and solutions."
"Healthcare and biotechnology will be called on to treat this enormous group of Americans and of course, publicly traded companies will capitalize on this vast new market. As the tech and Internet explosion of the late 1990's demonstrated, when a major consumer market emerges, the companies with sound and innovative technology will survive and thrive. From Alzheimer's to oncology, expect to see companies racing to serve the boomers."
The informational report "Innovations in Biotechnology" has been made available free of charge at www.SmallCapSentinel.com and will address medical, pharmaceutical and other emergent biotechnology companies such as Merck (NYSE:MRK), Amgen (Nasdaq:AMGN), The Sagemark Companies Ltd. (OTCBB:SKCO), and Pfizer Inc. (NYSE:PFE).
Sagemark owns, operates and administers out-patient medical diagnostic imaging centers that utilize positron emission tomography (PET), and PET and computed tomography (PET/CT) scanning equipment. PET is an advanced medical diagnostic imaging procedure used by physicians in the detection of certain cancers, coronary disease and neurological disorders including Alzheimer's disease. There are now six PET imaging centers in the company's growing portfolio of medical diagnostic imaging facilities.
Individuals may register to receive free future reports at: http://stockupticks.com/register.html
Statements made herein contain forward-looking statements and are subject to significant risks and uncertainties that will affect results. SmallCap Sentinel and StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect any proposed actions and cannot project capabilities, intent, resources, or experience.
All information contained herein is based upon sources believed to be reliable but no representation is made as to its accuracy or completeness. This report is neither a solicitation to buy nor an offer to sell securities but is rather a paid advertisement provided for information purposes only and should not be used as the basis for any investment decision. MP is not an investment advisor and this report is not investment advice. MP has been paid fifteen hundred dollars by McCloud Communications. for preparation and distribution of this report and other advertising services. This constitutes a conflict of interest as to MP's ability to remain objective in its communication regarding the subject companies.